slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 34,771-34,800
Pages 1,379
Rows per page 30
Component
34,771-34,800 of 41,369
53
Uses a three-pillar structure to categorize performance failures.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
62
The slide uses a stacked bar chart to visualize the shift in release windows. A red circle and annotation specifically call out Disney's 2022 data point.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
68
Uses a numbered list format to structure the critique of Disney's technological strategy.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
82
Blackwells Capital | Activist Presentation Deck | 115 slidesBlackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
93
Uses a color-coded matrix to contrast the qualifications of the nominees.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
96
The slide uses a red dashed line to emphasize the downward trend and a callout to quantify the performance failure.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
100
The slide uses a rhetorical question as a title to frame the data as evidence of a hidden relationship.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
103
Uses a 'quote-contradiction' framework to highlight potential hypocrisy in corporate governance.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
106
Uses a 'hypocrisy' framing by juxtaposing corporate values against specific actions.Blackwells Capital | Activist Presentation Deck | 115 slides · Blackwells Capital
Activist deck Activist investor 1 hit
05
The slide uses a rhetorical question as a title to frame the data as evidence of a potential bias or undisclosed relationship.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Analogy1 hit
08
Uses a 'before-after' or 'contradiction' framing by juxtaposing corporate policy text against specific company actions.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
11
Uses a 'hypocrisy' framing by juxtaposing corporate values against specific actions.Blackwells Capital | Activist Presentation Deck | 15 slides · Blackwells Capital
Activist deck Activist investor Beat · Expose ContradictionLoop · Cost Of Inaction1 hit
05
The slide uses a visual comparison framework to contrast current standard-of-care targets (mutations/fusions) with the company's focus (ecDNA).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
11
The slide uses a visual 'X' to indicate the lack of efficacy for amplifications across multiple drug classes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a color-coded matrix to illustrate clinical failure or limited efficacy in amplified tumors.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide uses a combination of microscopy images, a circular genomic plot (circos plot), and a diagram of cell division to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
16
Data source: Kim, Nguyen, Turner, et al. 2020 Nature Genetics. Analysis of WGS data from >3,000 tumor and matched normal samples.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
18
The slide uses a before-and-after experimental setup with microscopy images and longitudinal data plots to illustrate therapeutic resistance.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
26
The slide uses a comparative visual framework to contrast normal vs. stressed replication mechanisms.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
27
The slide uses a combination of a CRISPR screen scatter plot and a biological process diagram to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Solution (Provide relief)1 hit
30
Includes a mechanism of action diagram illustrating 'Therapy Enhanced Synthetic Lethality'.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
31
Shows synergistic effect of BBI-355 with Palbociclib and Erlotinib.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
39
The slide uses a biological mechanism diagram to explain the therapeutic rationale for BBI-825.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
44
The slide uses a diagram to link specific cancer types and mutations to resistance mechanisms, ultimately pointing to BBI-825 as the solution.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Market Size1 hit
47
Boundless Bio | IPO Presentation Deck | 51 slidesBoundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Loop · Golden Circle1 hit
48
The slide uses a timeline-style progression to frame the company's technology as the next logical evolution in cancer treatment.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Why NowLoop · Why Now1 hit
08
The chart uses a Gantt-style visualization to represent clinical trial phases for different indications.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
11
The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
14
The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.CARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
22
CARGO Therapeutics | IPO Presentation Deck | 29 slidesCARGO Therapeutics | IPO Presentation Deck | 29 slides · CARGO Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit